VTGN isn't even micro, it is nano cap 5:12 pm ET VistaGen Therapeutics Q1 EPS $(0.10) Down From $(0.04) YoY, Sales $310.00K Down From $354.10K YoY Benzinga Company is developing a nasal spray drug delivery to treat depression--like about two dozen more NASDAQ third tier companies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.